Sun Pharma Advanced Research Company Limited confirms its compliance with disclosure requirements regarding a recent increase in trading volume. The company states that all necessary disclosures have been made to the stock exchanges. They affirm their commitment to providing timely and adequate information in accordance with regulations. The announcement addresses queries related to the trading activity, assuring stakeholders of transparency.
Clarification on Trading Activity
Sun Pharma Advanced Research Company Limited has issued a clarification regarding a recent increase in the company’s trading volume. The company confirms that it adheres to the required disclosure norms.
Compliance and Disclosures
The company asserts that it is in full compliance with all applicable regulations and has made all necessary disclosures to the relevant stock exchanges. They also stated they are not aware of any information that would qualify for disclosure but has not been disclosed.
Commitment to Transparency
Sun Pharma Advanced Research Company Limited reiterates its commitment to maintaining transparency and ensuring that all stakeholders receive timely and accurate information. The company pledges to continue making adequate disclosures in compliance with existing regulations.
Source: BSE
